FROG JFrog Ltd Insider Trading

CTO Yoav Landman sold 100,000 shares of FROG for $8,146,952.43 via scheduled 10b5-1 plan; retains 5.73M shares.

Yoav Landman (Chief Technology Officer) executed three separate sales totaling 100,000 shares for $8,146,952.43 on 2026-06-01 at blended average price $81.47, reducing his holdings by 1.7% to 5,734,038 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-01, meaning the sales were scheduled rather than discretionary. His prior trades at FROG show 90-day returns of +38.6%, +36.4%, +40.6%, +35.2%, and +107.2%, indicating that stock appreciation has historically followed his sales at this ticker; however, the current price of $83.86 is +5.9% above the blended transaction price, and his cross-ticker track record of 20 prior sells averaged +11.7% 90-day return post-sale. JFrog remains unprofitable (net income $-8.3M most recent quarter) despite +24.1% annual revenue growth, and the company's $10.2B market cap reflects significant valuation relative to current earnings.

Director Frederic Simon sells 120,000 shares for $10.3M under 10b5-1 plan; retains 3.22M shares post-sale

Frederic Simon executed 9 separate sales totaling 120,000 shares for $10,300,766.73 on 2026-06-01, reducing his holdings from 3.34M to 3.22M shares (a -3.6% reduction). This transaction is part of a pre-arranged 10b5-1 trading plan adopted 2025-08-12, making it scheduled rather than discretionary. The company is unprofitable (full-year net income was negative) despite strong revenue growth of +24.1%, and the stock has risen 59.5% over the past 30 days and 104.0% over 90 days. Simon's 5 prior trades at FROG showed positive 30-day returns (ranging 35.1% to 40.6% on three May sales), though these prior outcomes cannot be attributed to his trading acumen given the mechanical nature of 10b5-1 execution. The scheduled nature of this filing limits what can be inferred about current conviction.

CEO Ben Haim Shlomi sold 51,237 shares of FROG at $75.02 on 2026-05-29 under 10b5-1 plan; stock now $88.05.

CEO Ben Haim Shlomi sold 51,237 shares at $75.02 on 2026-05-29, executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-03, meaning this was a scheduled transaction rather than discretionary. Post-transaction holdings remain substantial at 4,794,364 shares. The stock has appreciated significantly since the sale date (current price $88.05 versus transaction price $75.02), and his prior sales at FROG have also been followed by gains: five previous trades at this ticker showed 30-day returns ranging from +0.4% to +36.8% and 90-day returns from +35.1% to +58.4%. The company generated $153,977,000.00 in quarterly revenue with +24.1% annual growth but remains unprofitable with net income of $-8,267,000.00 over its most recent full fiscal year. The scheduled nature of this execution removes any timing inference; the consistently positive post-sale price movements in his FROG transaction history are observed facts but do not reflect discretionary decision-making in this filing.

CEO Ben Haim Shlomi sells 48,763 shares of FROG at $75.04 via pre-arranged 10b5-1 plan

Ben Haim Shlomi, as CEO, sold 48,763 shares (48.8K shares) for $3,659,175.52 ($3.7M) on 2026-05-26 at $75.04, reducing his holdings by 1.0% to 4,845,601 shares (4.85M shares). This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-03 and therefore represents a scheduled, non-discretionary sale rather than a discretionary market decision. The sale occurs when FROG stock is trading at $72.77, or -3.1% from its 52-week high of $75.08, and within a context where the stock has appreciated +59.9% over 30 days and +81.2% over 90 days. Across his prior five trades at FROG, Ben Haim Shlomi's sales have been followed by 30-day returns ranging from +0.4% to +36.8% and 90-day returns ranging from +35.1% to +58.4%, though the company remains unprofitable on a full-year basis with net income of $-8,267,000.00 ($-8.3M) despite quarterly revenue of $153,977,000.00 ($154.0M) and annual revenue growth of +24.1%.

JFrog CTO Yoav Landman sold 75,000 shares for $4.8M at avg $64.22/share under 10b5-1 plan on 2026-05-14.

Landman executed four separate sales totaling 75,000 shares ($4,816,294.52) under a pre-arranged 10b5-1 trading plan adopted 2025-09-01, reducing his holdings by 1.3% to 5,753,437 shares. As a scheduled transaction, no timing inference is warranted. His prior five trades at FROG have shown varied 90-day returns ranging from +16.5% to +55.7%, while his cross-ticker track record shows 20 prior sells with an average 90-day return of +1.6%. The company is growing revenue at +24.1% annually but remains unprofitable with net income of $-8,267,000.00 on revenue of $153,977,000.00, indicating the business has not yet achieved profitability despite substantial scale.

Director Simon Frederic sold 117,500 shares at $63.78 avg for $7.5M at FROG under 10b5-1 plan

Simon Frederic executed 4 separate sales totaling 117,500 shares for $7,493,881.13 under a pre-arranged 10b5-1 trading plan adopted on 2025-08-12, reducing his holdings by 3.4% to 3,340,786 shares. The transaction is scheduled rather than discretionary. JFrog trades at $67.91 currently, within its 52-week range of $34.05–$72.06, with stock performance up 53.9% over 30 days and +42.8% over 90 days. The company generated $154.0M in quarterly revenue with annual growth of +24.1%, though it reported a net loss of $-8.3M for the latest quarter and was unprofitable over the most recent full fiscal year.

FROG CEO Shlomi Ben Haim sells 25,000 shares for $1.3M amid stock recovery; consistent with pattern of frequent dispositions.

Shlomi Ben Haim, JFrog's CEO, has sold approximately 25,000 shares worth $1.3 million, continuing a persistent pattern of open-market dispositions that dominates his Form 4 activity over the past three years. The stock is currently trading well below its highs after a recent rally, but Ben Haim's historical results at this ticker show conflicting timing signals—his prior sales were well-timed in the near term as the stock dipped afterward, yet poorly timed over longer horizons as the stock recovered substantially. This sale adds to an overwhelming pattern of selling across his filing history, with over 60 prior open-market sales and no open-market purchases recorded, suggesting consistent capital reduction rather than any conviction play. The company remains unprofitable on an annual basis despite revenue growth, creating an uncertain backdrop where the CEO's repeated selling may reflect ordinary portfolio management or liquidity needs, but does not align with the capital-building activity typical of executives confident in near-term catalysts.